Don Griffin is an Assistant Professor in the Department of Biomedical Engineering at the University of Virginia. After his training in Biomedical Engineering at the University of California, Los Angeles, Don joined the faculty at the University of Virginia in 2017.
His lab works on creating advanced biomaterials to support both fundamental science and translational approaches to tissue regeneration. They engineer biomaterials using a unique combination of microscale geometric control and novel chemistries.
Our long-term goal is to exploit the unique targeting properties of contrast ultrasound in developing therpaeutic nanomedicine strategies for the improved treatment of limb claudication, myocardial ischemia, and solid tumors with poor surgical accessibility.
My laboratory currently uses several different strategies, including phage display, small molecule display on nanoparticles, and SELEX, to identify lead candidates for the development of amplifiable targeted imaging agents.
Our goal is to elucidate cellular mechanotransduction mechanisms as candidates for therapeutic cellular engineering.
We seek to develop broad classes of new tools for use in minimally invasive medical procedures in electrophysiology, cardiology and neurosurgery.